Export Ready — 

Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin‐6: relationship with peritoneal transport

Bibliographic Details
Main Author: Rodrigues, Anabela
Publication Date: 2004
Other Authors: Martins, M., Santos, M., Fonseca, Isabel, Carlos Oliveira, José, Cabrita, A., Castro e Melo, J., Krediet, R.
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10400.16/347
Summary: Peritoneal hyperpermeability has been associated with increased levels of effluent vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6). Mesothelial cells can produce various vasoactive substances besides VEGF. A large mesothelial mass may possibly lead to high dialysate VEGF concentrations and may partly explain some cases of peritoneal hyperpermeability during a patient’s early months on peritoneal dialysis (PD). Early peritoneal fast transport may therefore not necessarily be associated with systemic inflammation. To investigate the relationship of effluent markers and peritoneal transport, we measured the appearance rates of cancer antigen 125 (CA125), VEGF, and IL-6 in 4-hour effluents from 69 peritoneal equilibration tests (PETs) using 3.86% glucose solution. At the same time, we measured serum VEGF and IL-6. Our analyses included an early group (EG), whose members had been on PD for 4.6 ± 3.3 months, and a later group (LG), whose members had been on PD for 30 ± 17 months. In EG, dialysate-to-plasma creatinine at 4 hours (D/PCr240) correlated significantly with effluent CA125/min (r = 0.51, p = 0.006) and VEGF/min (r = 0.57, p = 0.001), but not with serum VEGF or IL-6. The values of CA125/min and VEGF/min also correlated (r = 0.40, p = 0.034). Fast transporters in EG had higher effluent CA125 (p = 0.057) and VEGF (p = 0.0001), but not serum or effluent IL-6. In LG, D/PCr240 again correlated significantly with dialysate VEGF(r = 0.51, p = 0.009), but not with CA125. Fast transporters in LG tended to have higher levels of serum and effluent IL-6 and effluent VEGF. We conclude that fast solute transport rates at the beginning of PD are associated with signs of a large mesothelial cell mass and not consistently associated with higher systemic IL-6. The VEGF produced by mesothelial cells can mediate early peritoneal hyperpermeability in some populations. Later, mesothelial mass is lost and is no longer related to increased intraperitoneal VEGF or IL-6.
id RCAP_4b644a845a8b81bcc26f4b4a264e4791
oai_identifier_str oai:repositorio.chporto.pt:10400.16/347
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin‐6: relationship with peritoneal transportPeritoneal transportmesothelial cellsvascular endothelialgrowth factorcancer antigen 125interleukin-6Peritoneal hyperpermeability has been associated with increased levels of effluent vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6). Mesothelial cells can produce various vasoactive substances besides VEGF. A large mesothelial mass may possibly lead to high dialysate VEGF concentrations and may partly explain some cases of peritoneal hyperpermeability during a patient’s early months on peritoneal dialysis (PD). Early peritoneal fast transport may therefore not necessarily be associated with systemic inflammation. To investigate the relationship of effluent markers and peritoneal transport, we measured the appearance rates of cancer antigen 125 (CA125), VEGF, and IL-6 in 4-hour effluents from 69 peritoneal equilibration tests (PETs) using 3.86% glucose solution. At the same time, we measured serum VEGF and IL-6. Our analyses included an early group (EG), whose members had been on PD for 4.6 ± 3.3 months, and a later group (LG), whose members had been on PD for 30 ± 17 months. In EG, dialysate-to-plasma creatinine at 4 hours (D/PCr240) correlated significantly with effluent CA125/min (r = 0.51, p = 0.006) and VEGF/min (r = 0.57, p = 0.001), but not with serum VEGF or IL-6. The values of CA125/min and VEGF/min also correlated (r = 0.40, p = 0.034). Fast transporters in EG had higher effluent CA125 (p = 0.057) and VEGF (p = 0.0001), but not serum or effluent IL-6. In LG, D/PCr240 again correlated significantly with dialysate VEGF(r = 0.51, p = 0.009), but not with CA125. Fast transporters in LG tended to have higher levels of serum and effluent IL-6 and effluent VEGF. We conclude that fast solute transport rates at the beginning of PD are associated with signs of a large mesothelial cell mass and not consistently associated with higher systemic IL-6. The VEGF produced by mesothelial cells can mediate early peritoneal hyperpermeability in some populations. Later, mesothelial mass is lost and is no longer related to increased intraperitoneal VEGF or IL-6.Peritoneal Dialysis Bulletin, Inc.Repositório Científico da Unidade Local de Saúde de Santo AntónioRodrigues, AnabelaMartins, M.Santos, M.Fonseca, IsabelCarlos Oliveira, JoséCabrita, A.Castro e Melo, J.Krediet, R.2010-07-29T16:57:28Z20042004-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.16/347eng1197-8554info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-26T10:09:30Zoai:repositorio.chporto.pt:10400.16/347Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T21:21:02.098370Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin‐6: relationship with peritoneal transport
title Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin‐6: relationship with peritoneal transport
spellingShingle Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin‐6: relationship with peritoneal transport
Rodrigues, Anabela
Peritoneal transport
mesothelial cells
vascular endothelial
growth factor
cancer antigen 125
interleukin-6
title_short Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin‐6: relationship with peritoneal transport
title_full Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin‐6: relationship with peritoneal transport
title_fullStr Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin‐6: relationship with peritoneal transport
title_full_unstemmed Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin‐6: relationship with peritoneal transport
title_sort Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin‐6: relationship with peritoneal transport
author Rodrigues, Anabela
author_facet Rodrigues, Anabela
Martins, M.
Santos, M.
Fonseca, Isabel
Carlos Oliveira, José
Cabrita, A.
Castro e Melo, J.
Krediet, R.
author_role author
author2 Martins, M.
Santos, M.
Fonseca, Isabel
Carlos Oliveira, José
Cabrita, A.
Castro e Melo, J.
Krediet, R.
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico da Unidade Local de Saúde de Santo António
dc.contributor.author.fl_str_mv Rodrigues, Anabela
Martins, M.
Santos, M.
Fonseca, Isabel
Carlos Oliveira, José
Cabrita, A.
Castro e Melo, J.
Krediet, R.
dc.subject.por.fl_str_mv Peritoneal transport
mesothelial cells
vascular endothelial
growth factor
cancer antigen 125
interleukin-6
topic Peritoneal transport
mesothelial cells
vascular endothelial
growth factor
cancer antigen 125
interleukin-6
description Peritoneal hyperpermeability has been associated with increased levels of effluent vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6). Mesothelial cells can produce various vasoactive substances besides VEGF. A large mesothelial mass may possibly lead to high dialysate VEGF concentrations and may partly explain some cases of peritoneal hyperpermeability during a patient’s early months on peritoneal dialysis (PD). Early peritoneal fast transport may therefore not necessarily be associated with systemic inflammation. To investigate the relationship of effluent markers and peritoneal transport, we measured the appearance rates of cancer antigen 125 (CA125), VEGF, and IL-6 in 4-hour effluents from 69 peritoneal equilibration tests (PETs) using 3.86% glucose solution. At the same time, we measured serum VEGF and IL-6. Our analyses included an early group (EG), whose members had been on PD for 4.6 ± 3.3 months, and a later group (LG), whose members had been on PD for 30 ± 17 months. In EG, dialysate-to-plasma creatinine at 4 hours (D/PCr240) correlated significantly with effluent CA125/min (r = 0.51, p = 0.006) and VEGF/min (r = 0.57, p = 0.001), but not with serum VEGF or IL-6. The values of CA125/min and VEGF/min also correlated (r = 0.40, p = 0.034). Fast transporters in EG had higher effluent CA125 (p = 0.057) and VEGF (p = 0.0001), but not serum or effluent IL-6. In LG, D/PCr240 again correlated significantly with dialysate VEGF(r = 0.51, p = 0.009), but not with CA125. Fast transporters in LG tended to have higher levels of serum and effluent IL-6 and effluent VEGF. We conclude that fast solute transport rates at the beginning of PD are associated with signs of a large mesothelial cell mass and not consistently associated with higher systemic IL-6. The VEGF produced by mesothelial cells can mediate early peritoneal hyperpermeability in some populations. Later, mesothelial mass is lost and is no longer related to increased intraperitoneal VEGF or IL-6.
publishDate 2004
dc.date.none.fl_str_mv 2004
2004-01-01T00:00:00Z
2010-07-29T16:57:28Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.16/347
url http://hdl.handle.net/10400.16/347
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1197-8554
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Peritoneal Dialysis Bulletin, Inc.
publisher.none.fl_str_mv Peritoneal Dialysis Bulletin, Inc.
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833599238411386880